# Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants

> **NCT07262281** · PHASE1 · RECRUITING · sponsor: **Newsoara Biopharma Co., Ltd.** · enrollment: 74 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** HY6725
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT07262281
- **Lead sponsor:** Newsoara Biopharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-06
- **Primary completion:** 2027-03
- **Final completion:** 2027-04
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07262281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07262281, "Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07262281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*